Cor Vasa 2007, 49(5):192-194
Drug therapy of arterial hypertension in patients with significant aortic stenosis.
- 1 Kardiovaskulární centrum, Fakultní nemocnice Motol, Praha
- 2 Centrum kardiovaskulární a transplantační chirurgie, Brno
- 3 II. interní klinika
- 4 I. interní klinika, Lékařská fakulta Univerzity Karlovy v Plzni, Plzeň, Česká republika
Arterial hypertension affects 30-70% patients with aortic stenosis. There are no specific recommendations for drug treatment of this population of patients; to date, no consensus has been reached over vasodilator administration. The aim of our study was to determine the incidence of hypertension and the proportion of medically treated patients with aortic stenosis at the time of indication for surgery.
Data from a comprehensive examination of 225 patients (mean age 68 ± 9 years; 41% of women) with significant non-rheumatic calcified aortic stenosis (mean gradient 54 ± 17 mmHg) were analyzed. Arterial hypertension was present in 68% of patients; of these, 87% were on drug therapy. Vasodilator therapy was given to 54% hypertensives with aortic stenosis.
In our group, arterial hypertension was diagnosed in more than two thirds of patients with significant aortic stenosis; most of them were receiving drug therapy, vasodilators were common in the treatment of hypertension.
Keywords: Hypertension; Aortic stenosis; ACE inhibitors; Aortic valve calcification
Published: May 1, 2007 Show citation
References
- Antonini-Canterin F, Huang G, Cervesato E, et al. Symptomatic aortic stenosis: Does systemic hypertension play an additional role? Hypertens 2003;41:1268-72.
Go to original source...
Go to PubMed...
- Bonow RO, Carabello B, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 2006;48:1486-588.
- Peltier M, Trojette F, Sarano ME, Grigioni F, Slama MA, Tribouilloy CM. Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with three-cuspid aortic valve. Am J Cardiol 2003;91:97-9.
Go to original source...
Go to PubMed...
- Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005;111:920-5.
Go to original source...
Go to PubMed...
- Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004;110:1291-5.
Go to original source...
Go to PubMed...
- Jimenez-Candil J, Bermejo J, Yotti R, et al. Effects of angiotensin converting enzyme inhibitors in hypertensive patients in aortic stenosis: a drug withdrawal study. Heart 2005;91:1311-8.
Go to original source...
Go to PubMed...
- O'Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002;106:2224-30.
Go to original source...
Go to PubMed...
- O'Brien KD, Probstfield JL, Caulfield MT, et al. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 2005;165:858-62.
Go to original source...
Go to PubMed...
- Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? Eur Heart J 2005;26:1790-6.
Go to original source...
Go to PubMed...